×
About 730 results

AACC Practical Recommendations for Implementing and Interpreting SARS-CoV-2 Emergency U...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8083777
Clinical Chemistry; Zhang YV, Wiencek J et. al.

Sep 2nd, 2021 - The clinical laboratory continues to play a critical role in managing the coronavirus pandemic. Numerous US Food and Drug Administration emergency use authorization (EUA) and laboratory-developed test (LDT) serologic assays have become available. The performance characteristics of these assays and their clinical utility continue to be defined in real time during this pandemic. The AACC convened...

2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Managemen...
https://doi.org/10.1002/acr.24632
Arthritis Care & Research; Maz M, Chung SA et. al.

Jul 9th, 2021 - To provide evidence-based recommendations and expert guidance for the management of giant cell arteritis (GCA) and Takayasu arteritis (TAK) as exemplars of large vessel vasculitis. Clinical questions regarding diagnostic testing, treatment, and management were developed in the population, intervention, comparator, and outcome (PICO) format for GCA and TAK (27 for GCA, 27 for TAK). Systematic li...

2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Managemen...
https://doi.org/10.1002/acr.24633
Arthritis Care & Research; Chung SA, Gorelik M et. al.

Jul 9th, 2021 - To provide evidence-based recommendations and expert guidance for the management of systemic polyarteritis nodosa (PAN). Twenty-one clinical questions regarding diagnostic testing, treatment, and management were developed in the population, intervention, comparator, and outcome (PICO) format for systemic, non-hepatitis B-related PAN. Systematic literature reviews were conducted for each PICO qu...

What Is the Antibody Response and Role in Conferring Natural Immunity After SARS-CoV-2 ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8017476
Annals of Internal Medicine; Qaseem A, Yost J et. al.

Mar 16th, 2021 - The widespread availability of SARS-CoV-2 antibody tests raises important questions for clinicians, patients, and public health professionals related to the appropriate use and interpretation of these tests. The Scientific Medical Policy Committee (SMPC) of the American College of Physicians developed these rapid, living practice points to summarize the current and best available evidence on th...

2021 update of the AGIHO guideline on evidence-based management of COVID-19 in patients...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874914
European Journal of Cancer (Oxford, England : 1990); Giesen N, Sprute R et. al.

Mar 7th, 2021 - The worldwide spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the associated infectious coronavirus disease (COVID-19) has posed a unique challenge to medical staff, patients and their families. Patients with cancer, particularly those with haematologic malignancies, have been identified to be at high risk to develop severe COVID-19. Since publication of our previ...

Glucocorticoid use in patients with adrenal insufficiency following administration of t...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7872824
Pituitary Katznelson L, Gadelha M

Feb 11th, 2021 - Side effects of the coronavirus disease 2019 (COVID-19) vaccines include pain at the injection site, fatigue, headache, myalgias, arthralgias, chills, and fever, all of which can be early indicators of an increased need for glucocorticoid replacement in patients with adrenal insufficiency. The Pituitary Society surveyed its membership to understand planned approaches to glucocorticoid managemen...

BSHI guideline: HLA matching and donor selection for haematopoietic progenitor cell tra...
https://doi.org/10.1111/iji.12527
International Journal of Immunogenetics; Little AM, Akbarzad-Yousefi A et. al.

Feb 11th, 2021 - A review of the British Society for Histocompatibility and Immunogenetics (BSHI) Guideline 'HLA matching and donor selection for haematopoietic progenitor cell transplantation' published in 2016 was undertaken by a BSHI appointed writing committee. Literature searches were performed and the data extracted were presented as recommendations according to the GRADE nomenclature.

Chest CT Diagnosis and Clinical Management of Drug-Related Pneumonitis in Patients Rece...
https://doi.org/10.1016/j.chest.2020.11.027
Chest Johkoh T, Lee KS et. al.

Jan 16th, 2021 - Use of molecular targeting agents and immune checkpoint inhibitors (ICIs) has increased the frequency and broadened the spectrum of lung toxicity, particularly in patients with cancer. The diagnosis of drug-related pneumonitis (DRP) is usually achieved by excluding other potential known causes. Awareness of the incidence and risk factors for DRP is becoming increasingly important. The severity ...

AGA Clinical Practice Update on Medical Management of Colonic Diverticulitis: Expert Re...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7878331
Gastroenterology Peery AF, Shaukat A et. al.

Dec 7th, 2020 - Colonic diverticulitis is a painful gastrointestinal disease that recurs unpredictably and can lead to chronic gastrointestinal symptoms. Gastroenterologists commonly care for patients with this disease. The purpose of this Clinical Practice Update is to provide practical and evidence-based advice for management of diverticulitis. We reviewed systematic reviews, meta-analyses, randomized contro...

FIGO/ICM guidelines for preventing Rhesus disease: A call to action.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898700
International Journal of Gynaecology and Obstetrics: the ... Visser GHA, Thommesen T et. al.

Nov 1st, 2020 - The introduction of anti-Rh(D) immunoglobulin more than 50 years ago has resulted in only a 50% decrease in Rhesus disease globally owing to a low uptake of this prophylactic approach. The International Federation of Gynecology and Obstetrics, International Confederation of Midwives, and Worldwide Initiative for Rhesus Disease Eradication have reviewed current evidence regarding the utility of ...

AGA Clinical Practice Update on Diagnosis and Management of Immune Checkpoint Inhibitor...
https://doi.org/10.1053/j.gastro.2020.08.063
Gastroenterology Dougan M, Wang Y et. al.

Oct 21st, 2020 - Immune checkpoint inhibitors (ICIs) have transformed the treatment landscape for oncology, leading to durable remissions in a subset of patients, but also a broad range of potentially life-threatening inflammatory toxicities, many of which involve the gastrointestinal (GI) tract and liver. The purpose of this expert review was to update gastroenterologists on the gastrointestinal and hepatic to...

Committee Opinion No. 407: Thyroid Disease and Infertility.
https://doi.org/10.1016/j.jogc.2020.08.004
Journal of Obstetrics and Gynaecology Canada : JOGC = Jou... Donovan L, Cockwell H et. al.

Oct 17th, 2020 - Committee Opinion No. 407: Thyroid Disease and Infertility.|2020|Donovan L,Cockwell H,Tallon N,Yamamoto J,|etiology,immunology,etiology,immunology,complications,

Convalescent Plasma for the Treatment of COVID-19: Perspectives of the National Institu...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556653
Annals of Internal Medicine; Pau AK, Aberg J et. al.

Sep 26th, 2020 - Convalescent Plasma for the Treatment of COVID-19: Perspectives of the National Institutes of Health COVID-19 Treatment Guidelines Panel.|2020|Pau AK,Aberg J,Baker J,Belperio PS,Coopersmith C,|immunology,therapy,methods,immunology,

National Psoriasis Foundation COVID-19 Task Force Guidance for Management of Psoriatic ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471802
Journal of the American Academy of Dermatology; Gelfand JM, Armstrong AW et. al.

Sep 7th, 2020 - To provide guidance about management of psoriatic disease during the coronavirus disease 2019 (COVID-19) pandemic. A task force (TF) of 18 physician voting members with expertise in dermatology, rheumatology, epidemiology, infectious diseases, and critical care was convened. The TF was supplemented by nonvoting members, which included fellows and National Psoriasis Foundation (NPF) staff. Clini...

Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice r...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471521
Supportive Care in Cancer : Official Journal of the Multi... Shannon VR, Anderson R et. al.

Sep 4th, 2020 - The immune checkpoints associated with the CTLA-4 and PD-1 pathways are critical modulators of immune activation. These pathways dampen the immune response by providing brakes on activated T cells, thereby ensuring more uniform and controlled immune reactions and avoiding immune hyper-responsiveness and autoimmunity. Cancer cells often exploit these regulatory controls through a variety of immu...

Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice r...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8507388
Supportive Care in Cancer : Official Journal of the Multi... Dougan M, Blidner AG et. al.

Aug 29th, 2020 - Immune-related adverse events (IrAEs) affecting the gastrointestinal (GI) tract and liver are among the most frequent and most severe inflammatory toxicities from contemporary immunotherapy. Inflammation of the colon and or small intestines (entero)colitis is the single most common GI IrAE and is an important cause of delay of discontinuation of immunotherapy. The severity of these GI IrAEs can...

Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice r...
https://doi.org/10.1007/s00520-020-05709-1
Supportive Care in Cancer : Official Journal of the Multi... Cooksley T, Girotra M et. al.

Aug 29th, 2020 - Immune checkpoint inhibitors (ICIs) have emerged as the newest pillar of cancer treatment, transforming outcomes in melanoma and showing benefit in a range of malignancies. Immune-mediated toxicities, stemming from increased activity within the T cell lineage, range from asymptomatic or mild complications to those that are fulminant and potentially fatal. Immune-mediated endocrinopathies includ...

Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice r...
https://doi.org/10.1007/s00520-020-05710-8
Supportive Care in Cancer : Official Journal of the Multi... Suarez-Almazor ME, Pundole X et. al.

Aug 29th, 2020 - Immune checkpoint inhibitors (ICIs) have emerged as the newest pillar of cancer treatment. Immune-mediated toxicities, stemming from increased activity within the T cell lineage, range from asymptomatic or mild complications to those that are fulminant and potentially fatal. Although they are of variable occurrence, cardiovascular, rheumatic, and renal immune-mediated toxicities are among the m...

Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice r...
https://doi.org/10.1007/s00520-020-05706-4
Supportive Care in Cancer : Official Journal of the Multi... Choi J, Anderson R et. al.

Aug 29th, 2020 - Immune checkpoint inhibitors (ICIs) frequently result in cutaneous immune-related adverse events (IrAEs). Although the majority of these events are mild-to-moderate in severity, up to 5% are severe, which may lead to morbidity and dose interruption or discontinuation of ICI therapy. In addition, up to 25% of dermatologic IrAEs are corticosteroid-refractory or corticosteroid-dependent. These 202...

Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert...
https://doi.org/10.1016/j.annonc.2020.07.010
Annals of Oncology : Official Journal of the European Soc... Curigliano G, Banerjee S et. al.

Aug 4th, 2020 - We established an international consortium to review and discuss relevant clinical evidence in order to develop expert consensus statements related to cancer management during the severe acute respiratory syndrome coronavirus 2-related disease (COVID-19) pandemic. The steering committee prepared 10 working packages addressing significant clinical questions from diagnosis to surgery. During a vi...